ask="23.70"
ask_size="500"
average_daily_volume="192848"
bid="12.15"
bid_size="100"
book_value="7.04"
change="+1.15"
change_from_200_day_moving_average="8.22"
change_from_50_day_moving_average="5.20"
change_from_52_week_high="-5.38"
change_From_52_week_low="11.45"
change_in_percent="+5.08%"
close="23.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.22"
eps_estimate_next_quarter="-0.97"
eps_estimate_next_year="-3.30"
ex_dividend_date="N/A"
float_shares="18671000"
high="24.10"
high_52_weeks="29.18"
last_trade_date="1/5/2017"
last_trade_price="23.80"
last_trade_size="18096"
last_trade_time="4:00pm"
low="22.35"
low_52_weeks="12.35"
market_capitalization="678.66M"
moving_average_200_day="15.58"
moving_average_50_day="18.60"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="34.60"
open="22.70"
pe_ratio="N/A"
peg_ratio="-0.56"
percent_change_from_200_day_moving_average="+52.76%"
percent_change_from_50_day_moving_average="+27.95%"
percent_change_from_52_week_high="-18.44%"
percent_change_from_52_week_low="+92.71%"
previous_close="22.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.22"
price_per_sales="2152.88"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="27.10"
stock_exchange="NGM"
symbol="RVNC"
volume="207855"
weeks_range_52="12.35 - 29.18"
